Micro Labs Limited — Irbesartan Exporter Profile
Indian Pharmaceutical Exporter · #12 for Irbesartan · $1.3M export value · DGFT Verified
Micro Labs Limited is the #12 Indian exporter of Irbesartan with $1.3M in export value and 41 verified shipments. Micro Labs Limited holds a 1.2% market share in Irbesartan exports across 6 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Irbesartan Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Irbesartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $564.7K | 22 | 48.6% |
| UNITED KINGDOM | $430.8K | 12 | 37.1% |
| GERMANY | $115.3K | 5 | 9.9% |
| BELGIUM | $50.0K | 1 | 4.3% |
| RUSSIA | $0 | 3 | 0.0% |
| BAHRAIN | $0 | 4 | 0.0% |
Micro Labs Limited exports Irbesartan to 6 countries. The largest destination is AUSTRALIA accounting for 48.6% of Micro Labs Limited's Irbesartan shipments, followed by UNITED KINGDOM (37.1%) and GERMANY (9.9%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irbesartan from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ARROW PHARMACEUTICALS PVT LTD | AUSTRALIA | $422.6K | 13 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $330.8K | 10 |
| BROWN AND BURK LIMITED | UNITED KINGDOM | $100.0K | 2 |
| MSK PHARMALOGISTIC GMBH | GERMANY | $65.3K | 4 |
| ARROW PHARMACEUTICALS PRIVATE LIMITED | AUSTRALIA | $61.7K | 4 |
| ARROW PHARMACEUTICALS PVT LTD ,- | AUSTRALIA | $54.3K | 2 |
| MSK PHARMALOGISTIC GMBH. | GERMANY | $50.0K | 1 |
| MICRO LABS GMBH , | BELGIUM | $50.0K | 1 |
| ARROW PHARMACEUTICALS PVT LTD, | AUSTRALIA | $26.1K | 3 |
| ALYONA CHORICH | RUSSIA | $0 | 3 |
Micro Labs Limited supplies Irbesartan to 11 buyers globally. The largest buyer is ARROW PHARMACEUTICALS PVT LTD (AUSTRALIA), followed by BROWN AND BURK UK LIMITED (UNITED KINGDOM) and BROWN AND BURK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irbesartan Export Value and How Much Does Micro Labs Limited Contribute?
India exported $58.2M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. Micro Labs Limited contributes $1.3M to this total, accounting for 1.2% of India's Irbesartan exports. Micro Labs Limited ships Irbesartan to 6 countries through 11 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Irbesartan Exports?
Micro Labs Limited's average Irbesartan shipment value is $30.8K per consignment, based on 41 shipments totaling $1.3M. The largest destination is AUSTRALIA (48.6% of Micro Labs Limited's Irbesartan exports).
How Does Micro Labs Limited Compare to Other Indian Irbesartan Exporters?
Micro Labs Limited ranks #12 among 123 Indian Irbesartan exporters with a 1.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($10.8M), MACLEODS PHARMACEUTICALS LTD ($8.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($8.3M). Micro Labs Limited processed 41 shipments to 6 destination countries.
What Irbesartan Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRBESARTAN FILM-COATED TABLETS 150 MG (B | $142.3K | 5 |
| IRBESARTAN 300mg FILM-COATED TABLETS ( ( | $100.0K | 2 |
| PHARMA:AVSARTAN 300 (IRBESARTAN 300MG FI | $91.6K | 2 |
| PHARMA:AVSARTAN 300(IRBESARTAN 300MG FIL | $87.4K | 2 |
| IRBESARTAN FILM-COATED TABLETS 150 MG B | $70.8K | 2 |
| PHARMA:AVSARTAN 150(IRBESARTAN 150MG FIL | $63.7K | 2 |
| IRBESARTAN 75MG FILM-COATED TABLETS BP | $50.0K | 1 |
| IRBESARTAN 300 MG FILM-COATED TABLETS IH IN BB LIVERY INV.QTY.34440 PACK 4X 7S | $50.0K | 1 |
| AVSARTAN IRBESARTAN 150MG IRBESARTAN 150MG FILM COATED TABLETS 3X10sX80880 -TAX DOCUMENT NO: 706204846 DT: 14.09.23 | $50.0K | 1 |
| AVSARTAN 300 IRBESARTAN 300 MG FILM COATED TABLETS BP PACK 3X10S DOCUMENT QTY96080 TAX DOCUMENT NO.706204911 | $50.0K | 1 |
Micro Labs Limited exports 32 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN FILM-COATED TABLETS 150 MG (B with 5 shipments worth $142.3K.
Regulatory Requirements: Exporting Irbesartan to Key Markets
What Micro Labs Limited must comply with to export Irbesartan to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Irbesartan Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | INTAS PHARMACEUTICALS LIMITED | $1.8M | 156 | 5 | $11.5K |
| 11 | JUBILANT GENERICS LIMITED | $1.3M | 84 | 7 | $15.1K |
| 12 | MICRO LABS LIMITED ★ | $1.3M | 41 | 6 | $30.8K |
| 13 | AUROBINDO PHARMA LIMITED | $1.2M | 109 | 3 | $11.2K |
| 14 | MEPRO PHARMACEUTICALS PRIVATE LIMITED | $1.0M | 71 | 1 | $14.8K |
Micro Labs Limited ranks #12 among 123 Indian Irbesartan exporters. Average shipment value of $30.8K compared to the market average of $473.0K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and JUBILANT GENERICS LIMITED.
Which Indian Ports Ship Irbesartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 284 | 10.6% |
| SAHAR AIR | 197 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 147 | 5.5% |
| DELHI AIR | 135 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 133 | 5.0% |
| JNPT | 129 | 4.8% |
| MUNDRA SEA (INMUN1) | 108 | 4.0% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Irbesartan Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Irbesartan, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 47 individual customs records matching Micro Labs Limited exporting Irbesartan, covering 32 formulations to 6 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Irbesartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Irbesartan Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current shipment-level data, contact TransData Nexus.